PLA/PLGA Injectable Microspheres

Description: The Shanghai Institute of Planned Parenthood Research (SIPPR) is developing a long-acting, injectable PLA/PLGA microsphere formulation for delivery of LNG for up to 6 months.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Injectable

Duration Type: Short-acting

Duration: 6 months

Regimen:
  • single injection

Active Pharmaceutical Ingredient (API):
  • levonorgestrel

Inactive material: PLA; PLGA

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Shanghai Institute of Planned Parenthood Research (SIPPR), FHI 360

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Pre-clinical

Began discovery in: 2013

Active Development: Yes

Status Details:
  • In vivo PK data in rats indicates 6-7 months release for select formulations.

Additional Information

References:

Vertical Tabs

Print